Article citationsMore>>
Holmes, C., Ballard, C., Lehman, D., David Smith, A., Beaumont, H., Day, I.N., Nadeem Khan, M., Lovestone, S., McCulley, M., Morris, C.M., Munoz, D.G., O’Brien, K., Russ, C., Del Ser, T. and Warden, D. (2005) Rate of Progression of Cognitive Decline in Alzheimer’s Disease: Effect of Butyrylcholinesterase K Gene Variation. Journal of Neurology, Neurosurgery & Psychiatry, 76, 640-643. http://dx.doi.org/10.1136/jnnp.2004.039321
has been cited by the following article:
-
TITLE:
Prevalence of Wild-Type Butyrylcholinesterase Genotype in Patients with Alzheimer’s Dementia
AUTHORS:
Beate Mueller, Georg Adler
KEYWORDS:
Butyrylcholinesterase, Alzheimer’s Disease, Genotype
JOURNAL NAME:
World Journal of Neuroscience,
Vol.5 No.3,
June
2,
2015
ABSTRACT: Approximately, two-thirds patients
with Alzheimer’s disease (AD) are reported to have homozygous wild-type
butyrylcholinesterase (BuChE) gene expression. It is associated with a higher
rate of hydrolysis of acetylcholine, which ultimately leads to increase in the
levels of BuChE in advanced stages of the disease. Rivastigmine, a dual
inhibitor of acetylcholinesterase (AChE) and BuChE, might be of additional
benefit in patients with AD with wild-type BuChE allele.
Related Articles:
-
Hervé A. N’cho, Innocent K. Kouame, Kouadio Koff, Lazare K. Kouassı, Séraphin K. Konan, Ruth Baï, Andrei Sandu, Ion Sandu
-
Tanoh-Aka Aude Hélène, Siallou-Avi Christelle, Yao Kouassi Christian, Adou Leïoh Roméo, Yeboua Kossonou Roland, Sahi Landryse, Amani Alexise, Tuo Wako Tianwa Alice, Gawa Kokora Junior, Asse Kouadio Vincent
-
Du Thanh Hang, Than Thi Thanh Tra, Le Minh Tuan, Geoffrey Peter Savage
-
Sangaré Naminata, Kouassi Edith Kwa-Koffi, Kouassi Aka Marcel, Yao Koffi Marcellin
-
Gumpeny Ramachandra Sridhar, Talluri Sekhar, Padmanabhuni Venkata Nageswara Rao, Allam Appa Rao